Collaborative Arrangements - Merck KGaA (Details) - Subsequent Event - Merck KGaA	Jan. 10, 2017 USD ($) pre-clinical_stage_program clinical-stage_program development_program
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Right to license, number of development programs | development_program	4
Right to license, number of clinical stage programs | clinical-stage_program	2
Number of pre-clinical stage programs | pre-clinical_stage_program	2
Up-front payment | $	$ 230,000,000.0
Time period of notice required to terminate	90 days
Time period of notice required to terminate after product has received marketing approval	180 days